CMS Halts Medicare Advantage Enrollment for Elevance Health Over 'Knowing Noncompliance'

Summary

The Centers for Medicare and Medicaid Services (CMS) has suspended Elevance Health from enrolling new members in its Medicare Advantage plans starting March 31, 2026, citing a seven-year pattern of failing to submit required regulatory information. The rare and severe sanction comes after what CMS officials described as "knowing noncompliance" by the insurance giant, though the suspension will not affect the company's existing 1.9 million Medicare Advantage enrollees.

Elevance's stock tumbled more than 8% following the announcement, reflecting investor concern about the potential financial impact. CMS indicated that if Elevance takes corrective action this month, the enrollment suspension could be lifted before Medicare's crucial annual enrollment period begins in October. The company faces significant financial pressure to resolve the compliance issues quickly, as inability to enroll new members during the fall enrollment window could severely impact revenue.

This enforcement action represents one of the most significant regulatory penalties CMS has imposed on a major Medicare Advantage insurer in recent years. Medicare Advantage, the private insurance alternative to traditional Medicare, has become increasingly lucrative for insurers, making enrollment restrictions particularly impactful. The suspension highlights growing regulatory scrutiny of Medicare Advantage plans amid concerns about industry practices and compliance.

• CMS characterized Elevance's conduct as demonstrating a "pattern of knowing noncompliance" and offered the company a path to lift the suspension by taking corrective action in March